![Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia](https://oncodaily.com/pub/uploads/2024/05/photo-collage.png-3-1280x720.png)
Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia
Ruzanna Papyan recently shared a post by Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, on Linkedin, adding:
“Discover more about our controlled trial, exploring the effectiveness of continuous infusion of first-generation 5-HT3 receptor antagonists combined with dexamethasone in alleviating chemotherapy-induced nausea and vomiting in pediatric cancer patients. Stay updated for developments and as our mentor often reminds us, ‘The best is yet to come!'”
Quoting Julia Hoveyan’s post:
“A year ago, the Immune Oncology Research Institute launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia.
This randomized controlled trial, titled ‘Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination with Dexamethasone: Can This Modality Improve the Antiemetic Effect?’ seeks to identify more effective methods for preventing chemotherapy-induced nausea and vomiting. Despite numerous challenges, the trial has been made possible by a dedicated and exceptional team.
Today, we are thrilled to report that, one year in, we have enrolled 23 patients and completed over 85 chemotherapy cycles. We anticipate concluding the trial and publishing our initial data by June 2025.
Thank you to the Immune Oncology Research Institute and Pediatric Cancer and Blood Disorders Center of Armenia for making clinical trials real in pediatric oncology in Armenia.
The best is yet to come!”
Sources: Ruzanna Papyan/LinkedIn and Julia Hoveyan/LinkedIn
Julieta Hoveyan, MD is a pediatric oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan. Dr. Hoveyan’s scientific interests are pediatric CNS tumors, cancer biology, and immune-oncology. Currently, she is a virtual pediatric neuro-oncology fellow at the St. Jude Children’s Research Hospital.
Ruzanna Papyan is a pediatric oncologist and clinical research physician at the Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. Yeolyan. She is also Head of the Musculoskeletal Multidisciplinary Working Group and Assistant Professor at the Department of Pediatric Oncology and Hematology at Yerevan State Medical University.